Effects of type 2 diabetes mellitus in patients on treatment with glibenclamide and metformin on carvedilol enantiomers metabolism (2017)
- Authors:
- USP affiliated authors: COELHO, EDUARDO BARBOSA - FMRP ; LANCHOTE, VERA LUCIA - FCFRP
- Unidades: FMRP; FCFRP
- DOI: 10.1002/jcph.864
- Subjects: DIABETES MELLITUS; ANTAGONISTAS; RECEPTORES ADRENÉRGICOS; FREQUÊNCIA CARDÍACA
- Keywords: Carvedilol; Enantiomers; Metabolism; Pharmacokinetics; Type 2 diabetes mellitus
- Agências de fomento:
- Language: Inglês
- Imprenta:
- Source:
- Título: The Journal of Clinical Pharmacology
- ISSN: 0091-2700
- Volume/Número/Paginação/Ano: v. 57, n. 6, p. 760-769, 2017
- Status:
- Artigo possui versão em acesso aberto em repositório (Green Open Access)
- Versão do Documento:
- Versão publicada (Published version)
- Acessar versão aberta:
-
ABNT
NARDOTTO, Glauco H. B. et al. Effects of type 2 diabetes mellitus in patients on treatment with glibenclamide and metformin on carvedilol enantiomers metabolism. The Journal of Clinical Pharmacology, v. 57, n. 6, p. 760-769, 2017Tradução . . Disponível em: https://doi.org/10.1002/jcph.864. Acesso em: 01 abr. 2026. -
APA
Nardotto, G. H. B., Coelho, E. B., Paiva, C. E., & Lanchote, V. L. (2017). Effects of type 2 diabetes mellitus in patients on treatment with glibenclamide and metformin on carvedilol enantiomers metabolism. The Journal of Clinical Pharmacology, 57( 6), 760-769. doi:10.1002/jcph.864 -
NLM
Nardotto GHB, Coelho EB, Paiva CE, Lanchote VL. Effects of type 2 diabetes mellitus in patients on treatment with glibenclamide and metformin on carvedilol enantiomers metabolism [Internet]. The Journal of Clinical Pharmacology. 2017 ; 57( 6): 760-769.[citado 2026 abr. 01 ] Available from: https://doi.org/10.1002/jcph.864 -
Vancouver
Nardotto GHB, Coelho EB, Paiva CE, Lanchote VL. Effects of type 2 diabetes mellitus in patients on treatment with glibenclamide and metformin on carvedilol enantiomers metabolism [Internet]. The Journal of Clinical Pharmacology. 2017 ; 57( 6): 760-769.[citado 2026 abr. 01 ] Available from: https://doi.org/10.1002/jcph.864 - Influence of quinidine, fluvoxamine, and ketoconazole on the enantioseletive pharmacokinetics of citalopram in rats
- Enantioselectivity in the pharmacokinetic interaction between fluvastatin and lercanidipine in healthy volunteers
- Influence of type-2 diabetes mellitus on the stereoselective kinetic disposition of fluvastatin
- Stereoselective analysis of metoprolol and its metabolites inrat plasma with application to oxidative metabolism
- Effect of hypertension on the stereoselective pharmacokinetics of fluvastatin in rats
- Lercanidipine-fluvastatin interaction: pharmacokinetics stereoselectivity in experimental study
- Enantioselectivity in fluvastatin-lercanidipine pharmacokinetics interaction in healthy volunteers
- Chiral evaluation of fluvastatin in human plasma by high-performance liquid chromatography electrospray mass spectometry
- Stereospecific pharmacodymamics/pharmacokinetics of metoprolol in rats
- Effect of CYP inhibitors on the stereoselective kinetic disposition of metoprolol in rats
Informações sobre a disponibilidade de versões do artigo em acesso aberto coletadas automaticamente via oaDOI API (Unpaywall).
Por se tratar de integração com serviço externo, podem existir diferentes versões do trabalho (como preprints ou postprints), que podem diferir da versão publicada.
How to cite
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
